A carregar...
IMMU-30. HIGH-DIMENSIONAL PHENOTYPING OF IMMUNE SUBSETS AND CHECKPOINTS IN THE MOUSE GLIOBLASTOMA MICROENVIRONMENT
Recent clinical trials in glioblastoma have yet to show any benefit of immune checkpoint inhibitors and are mostly driven by the fact that these inhibitors have efficacy in other cancer types. For immunotherapy to succeed in glioblastoma patients, we need to understand the immunological subsets and...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216265/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.533 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|